Altiplano Metals seeks regulator extension to file overdue annual financial statements
Bitget2026/09/28 19:05- Altiplano Metals sought a regulatory extension to Oct. 5, 2026 to file audited annual financial statements for fiscal 2026.
- A management cease trade order issued July 31, 2026 restricts trading by the CEO and CFO until filings are completed.
- Audit work is about 95% complete; remaining procedures hinge on third-party confirmations tied to minor tax matters.
- Annual filings were due July 29, 2026; first-quarter interim financial statements targeted for filing by Oct. 9, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uncertainty clouds the US stock IPO market as smart ring manufacturer Oura (OURA.US) joins the ranks of delayed listings
Oura (OURA.US) has become the latest company to postpone its initial public offering (IPO) in the United States due to market uncertainty.
Iovance Biotherapeutics Raises 2026 Revenue Guidance
AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation
Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.